Bilirubin was normal. Because of concerns about possible combined pulmonary and hepatic nitrofurantoin toxicity, it was recommended that the patient stop taking the prophylactic nitrofurantoin. A second biopsy of the RLL lung mass was performed to obtain additional tissue for molecular analysis.